SBC Medical Reports Mixed Results: Revenue Drops Amid Profitability Gains — SBC Medical Group Holdings Incorporated

Event summary

Total revenues declined by 15% year-over-year to $174 million for full-year 2025, with a 11% drop in Q4.
Net income attributable to SBC Medical increased by 9% year-over-year to $51 million for the full year, and by 117% in Q4.
EBITDA decreased by 35% year-over-year in Q4 but normalized to a more sustainable margin of 40% for the full year.
Number of franchise locations increased by 34 to 283 as of December 31, 2025.

The big picture

SBC Medical's full-year 2025 results reflect a business in transition, with deliberate structural changes leading to a revenue decline but underlying profitability improvements. The company is now focused on sustainable growth through strategic initiatives in dermatology, non-aesthetic healthcare, and international markets.

What we're watching

Multi-Brand Strategy: The company's focus on advancing its multi-brand strategy in the dermatology segment will be critical to watch, as it aims to drive sustainable top-line growth.
International Expansion: SBC Medical's efforts to build a stronger foundation in international markets could impact its long-term growth prospects and market positioning.
Customer Engagement: The early impact of pricing and customer engagement initiatives on average revenue per customer will be an important indicator of the company's operational momentum.